2.99% 1.55

Bridgebio Pharma Inc (BBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BBIO? Forum Prognose

Finanzdaten der Bridgebio Pharma Inc-Aktie (BBIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.20% 110.56	116.63	5.882	2.732	2.168
Cost Of Revenue	38.42% 3.653	2.639	2.084	0.598	0.598
Gross Profit	6.21% 106.91	113.99	3.798	2.134	1.57
Operating Expenses	10.45% 241.19	218.37	229.82	193.88	177.11
Benefits Costs and Expenses	2.09% 292.22	286.24	272.12	166.99	77.71
Costs And Expenses	10.79% 244.84	221.00	231.91	194.48	177.71
Operating Income/Loss	28.65% -134.28	-104.37	-226.03	-191.75	-175.54
Nonoperating Income/Loss	27.37% -47.38	-65.24	-40.21	27.50	100.00
Income/Loss Before Equity Method Investments	4.81% -161.47	-154.05	-249.54	-157.69	-67.62
Income/Loss From Equity Method Investments	29.78% -20.19	-15.56	-16.70	-6.563	-7.925
Income/Loss From Continuing Operations Before Tax	7.10% -181.66	-169.61	-266.24	-164.25	-75.54
Income Tax Expense/Benefit	2.10	-	1.153	-	-
Income/Loss From Continuing Operations After Tax	8.34% -183.76	-169.61	-267.39	-164.25	-75.54
Net Income/Loss	8.34% -183.76	-169.61	-267.39	-164.25	-75.54
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	15.14% -1.855	-2.186	-2.339	-2.214	-2.088
Basic Average Shares	0.20% 190.52	190.15	1.1287	188.51	187.59
Diluted Average Shares	0.20% 190.52	190.15	1.1287	188.51	187.59
Basic Earnings Per Share	7.95% -0.95	-0.88	-1.42	-0.86	-0.39
Diluted Earnings Per Share	7.95% -0.95	-0.88	-1.42	-0.86	-0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%